BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.63B |
| 2 |
Apple
AAPL
|
+$326M |
| 3 |
iShares US Real Estate ETF
IYR
|
+$260M |
| 4 |
Health Care Select Sector SPDR Fund
XLV
|
+$258M |
| 5 |
Utilities Select Sector SPDR Fund
XLU
|
+$246M |
Top Sells
| 1 |
AGN.PRA
Allergan plc.
AGN.PRA
|
+$239M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$188M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$172M |
| 4 |
Amazon
AMZN
|
+$122M |
| 5 |
Johnson & Johnson
JNJ
|
+$95.8M |
Sector Composition
| 1 | Technology | 10.7% |
| 2 | Financials | 9.69% |
| 3 | Communication Services | 8.5% |
| 4 | Consumer Discretionary | 7.98% |
| 5 | Healthcare | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Northfield Bancorp
NFBK
$492M
| $224K | ﹤0.01% |
14,351
-8,121
| -36% | -$127K |
|
2127
Preferred Bank
PFBC
$1.16B
| $224K | ﹤0.01% |
3,488
-1,710
| -33% | -$110K |
|
|
DLPH
2128
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $223K | ﹤0.01% |
4,678
-14,838
| -76% | -$707K |
|
2129
Schneider National
SNDR
$4.18B
| $222K | ﹤0.01% |
8,528
-5
| -0.1% | -$130 |
|
|
CYS
2130
DELISTED
CYS Investments Inc.
CYS
| $222K | ﹤0.01% |
33,014
-21,273
| -39% | -$143K |
|
2131
Axogen
AXGN
$755M
| $222K | ﹤0.01% |
6,073
+452
| +8% | +$16.5K |
|
2132
E.W. Scripps
SSP
$257M
| $221K | ﹤0.01% |
18,422
-10,303
| -36% | -$124K |
|
|
LL
2133
DELISTED
LL Flooring Holdings, Inc.
LL
| $221K | ﹤0.01% |
9,230
-2,631
| -22% | -$62.9K |
|
|
BNCL
2134
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $221K | ﹤0.01% |
14,191
-7,710
| -35% | -$120K |
|
|
AFSI
2135
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $221K | ﹤0.01% |
17,924
-7,814
| -30% | -$96.2K |
|
2136
Modine Manufacturing
MOD
$7.86B
| $221K | ﹤0.01% |
10,429
-94,872
| -90% | -$2.01M |
|
2137
Amphastar Pharmaceuticals
AMPH
$1.3B
| $221K | ﹤0.01% |
11,763
-2,922
| -20% | -$54.8K |
|
|
NATI
2138
DELISTED
National Instruments Corp
NATI
| $220K | ﹤0.01% |
4,360
-17,614
| -80% | -$891K |
|
2139
Theravance Biopharma
TBPH
$720M
| $220K | ﹤0.01% |
9,060
+395
| +5% | +$9.58K |
|
|
SNR
2140
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $220K | ﹤0.01% |
26,839
+6,291
| +31% | +$51.5K |
|
2141
Kadant
KAI
$3.69B
| $220K | ﹤0.01% |
2,323
+100
| +4% | +$9.45K |
|
2142
KB Financial Group
KB
$31.1B
| $219K | ﹤0.01% |
3,788
+1,907
| +101% | +$110K |
|
2143
Amkor Technology
AMKR
$6.29B
| $219K | ﹤0.01% |
21,647
-12,503
| -37% | -$127K |
|
2144
First Hawaiian
FHB
$3.19B
| $219K | ﹤0.01% |
7,854
-6,839
| -47% | -$190K |
|
|
KL
2145
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $218K | ﹤0.01% |
14,132
-4,607
| -25% | -$71.2K |
|
2146
John Wiley & Sons Class A
WLY
$2.19B
| $218K | ﹤0.01% |
3,429
-7,078
| -67% | -$451K |
|
|
CUTR
2147
DELISTED
Cutera, Inc.
CUTR
| $218K | ﹤0.01% |
4,343
-1,242
| -22% | -$62.4K |
|
2148
Metallus
MTUS
$697M
| $217K | ﹤0.01% |
14,274
-2,134
| -13% | -$32.4K |
|
|
IMGN
2149
DELISTED
Immunogen Inc
IMGN
| $217K | ﹤0.01% |
20,606
+100
| +0.5% | +$1.05K |
|
|
ADAM
2150
Adamas Trust, Inc. Common Stock
ADAM
$644M
| $216K | ﹤0.01% |
9,119
-771
| -8% | -$18.3K |
|